SCHEMBL6850865

SCHEMBL6850865

Cc1occc1COc1nc(Br)cnc1NS(=O)(=O)c1cccc(Cl)c1Cl.O=S(=O)(Nc1ncc(Br)nc1OCc1ccsc1)c1cccc(Cl)c1Cl

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 20/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1732030 0.91 CCR4 (0.66) CCR4
SCHEMBL1732193 0.90 CCR4 (0.66) CCR4
SCHEMBL1732592 0.78 CCR4 (0.72) CCR4
SCHEMBL1733007 0.78 CCR4 (0.66) CCR4
SCHEMBL1732100 0.77 CCR4 (0.81) CCR4
SCHEMBL1733023 0.76 CCR4 (0.68) CCR4
SCHEMBL1732955 0.75 CCR4 (0.82) CCR4
SCHEMBL1732988 0.74 CCR4 (0.70) CCR4
SCHEMBL1732021 0.74 CCR4 (0.90) CCR4
SCHEMBL1732694 0.73 CCR4 (0.67) CCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1467976-A1 N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES AstraZeneca AB (SE) 2004-10-20 EP claimed
WO-2003059893-A1 N-PYRAZINYL-PHENYLSULPHONAMIDES AND THEIR USE IN THE TREATMENT OF CHEMOKINE MEDIATED DISEASES ASTRAZENECA AB (SE) 2003-07-24 WO claimed